Medicenna Therapeutics Statistics
Total Valuation
MDNAF has a market cap or net worth of 55.31 million. The enterprise value is 37.13 million.
| Market Cap | 55.31M |
| Enterprise Value | 37.13M |
Important Dates
The last earnings date was Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 83.38M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.10% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 56.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.16 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.23 |
Financial Position
The company has a current ratio of 6.35, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.35 |
| Quick Ratio | 6.21 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -97.22% and return on invested capital (ROIC) is -104.31%.
| Return on Equity (ROE) | -97.22% |
| Return on Assets (ROA) | -53.68% |
| Return on Invested Capital (ROIC) | -104.31% |
| Return on Capital Employed (ROCE) | -85.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -456,280 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.82% in the last 52 weeks. The beta is 1.72, so MDNAF's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -55.82% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 45.19 |
| Average Volume (20 Days) | 25,614 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.20M |
| Pretax Income | -8.21M |
| Net Income | -8.21M |
| EBITDA | -14.18M |
| EBIT | -14.20M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has 17.28 million in cash and 116,882 in debt, giving a net cash position of 17.16 million.
| Cash & Cash Equivalents | 17.28M |
| Total Debt | 116,882 |
| Net Cash | 17.16M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 13.28M |
| Book Value Per Share | 0.17 |
| Working Capital | 16.51M |
Cash Flow
In the last 12 months, operating cash flow was -11.47 million and capital expenditures -22,959, giving a free cash flow of -11.50 million.
| Operating Cash Flow | -11.47M |
| Capital Expenditures | -22,959 |
| Free Cash Flow | -11.50M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MDNAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -14.85% |
| FCF Yield | -20.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |